107 related articles for article (PubMed ID: 7002338)
21. Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.
Tamura M; Inoue H; Murata M; Koizumi H; Nakamura M; Yonome I; Niibe H
J Cancer Res Clin Oncol; 1985; 109(3):188-92. PubMed ID: 4008513
[TBL] [Abstract][Full Text] [Related]
22. Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors.
Rosenthal DI; Close LG; Lucci JA; Schold SC; Truelson J; Fathallah-Skaykh H; Kamen B; Vuitch FM; Gazdar AF; Griener J
Semin Oncol; 1995 Aug; 22(4 Suppl 9):13-7. PubMed ID: 7644923
[TBL] [Abstract][Full Text] [Related]
23. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
Nelson DF; Diener-West M; Weinstein AS; Schoenfeld D; Nelson JS; Sause WT; Chang CH; Goodman R; Carabell S
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
[TBL] [Abstract][Full Text] [Related]
24. Radiation Therapy Oncology Group clinical trials with misonidazole.
Wasserman TH; Stetz J; Phillips TL
Cancer; 1981 May; 47(10):2382-90. PubMed ID: 7023642
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Asakawa H; Watarai J; Hoshino T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
[TBL] [Abstract][Full Text] [Related]
26. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase.
Chatani M; Matayoshi Y; Masaki N; Inoue T
Strahlenther Onkol; 1994 Mar; 170(3):155-61. PubMed ID: 8160096
[TBL] [Abstract][Full Text] [Related]
27. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
29. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.
Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R
Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737
[TBL] [Abstract][Full Text] [Related]
30. A preliminary clinical study in the use of misonidazole in cancer of the head and neck.
Sealy R
Br J Cancer Suppl; 1978 Jun; 3():314-7. PubMed ID: 277253
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
32. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
Grdina DJ; Sigdestad CP; Jovonovich JA
Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
[TBL] [Abstract][Full Text] [Related]
33. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.
Jones DH; Bleehen NM; Workman P; Smith NC
Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878
[TBL] [Abstract][Full Text] [Related]
34. Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study.
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):39-42. PubMed ID: 6343091
[TBL] [Abstract][Full Text] [Related]
35. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
37. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
Williams K; Begg E; Wade D; O'Shea K
Clin Pharmacol Ther; 1983 Mar; 33(3):314-21. PubMed ID: 6825387
[TBL] [Abstract][Full Text] [Related]
38. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
[TBL] [Abstract][Full Text] [Related]
39. The role of dexamethasone in the modification of misonidazole pharmacokinetics.
Jones DH; Bleehen NM; Workman P; Walton MI
Br J Cancer; 1983 Oct; 48(4):553-7. PubMed ID: 6626454
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
